First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer. - Peters S; Piha-Paul SA; Sehgal K; Calvo E; Bockorny B; Galvao V; Dowlati A; Fontana E; Hernandez-Guerrero T; Rivera Herrero F; Kingsley E; Lopez JS; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026)